Overexpression of miR-133a could decrease doxorubicin resistance in the MCF-7/Dox breast cancer cell line by decreasing the expression of mitochondrial uncoupling protein 2 (UCP-2) [10]. Here, UCP2 is linked to breast carcinoma.